• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Emergency department management of opioid use disorder in pediatric patients.儿科患者阿片类物质使用障碍的急诊科管理
J Am Coll Emerg Physicians Open. 2024 Aug 25;5(5):e13265. doi: 10.1002/emp2.13265. eCollection 2024 Oct.
2
METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES.美沙酮在急诊科用于治疗阿片类药物使用障碍：病例系列。
J Emerg Med. 2023 Mar;64(3):391-396. doi: 10.1016/j.jemermed.2023.01.012.
3
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.在阿片类药物治疗项目中开始使用美沙酮或丁丙诺啡/纳洛酮的不同阿片类物质使用障碍患者样本中的神经认知、精神和物质使用特征。
Addict Sci Clin Pract. 2021 Oct 24;16(1):64. doi: 10.1186/s13722-021-00272-4.
4
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.美国退伍军人事务部的多药物使用与阿片类药物使用障碍治疗的关系。
Addiction. 2021 Jan;116(1):96-104. doi: 10.1111/add.15116. Epub 2020 Jul 7.
5
Pain Management Considerations in Patients With Opioid Use Disorder Requiring Critical Care.需要重症监护的阿片类药物使用障碍患者的疼痛管理考量
J Clin Pharmacol. 2022 Apr;62(4):449-462. doi: 10.1002/jcph.1999. Epub 2022 Jan 5.
6
Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.在物质使用障碍治疗环境中，对接受医疗补助的阿片类药物使用障碍患者进行丙型肝炎病毒筛查。
Subst Use Misuse. 2021;56(2):258-263. doi: 10.1080/10826084.2020.1858106. Epub 2020 Dec 21.
7
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.不同阿片类药物使用障碍治疗途径的疗效比较。
JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622.
8
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.在美国商业保险人群中，接受阿片类药物使用障碍治疗的个体中，可注射纳曲酮、口服纳曲酮和丁丙诺啡的使用和停药情况。
J Subst Abuse Treat. 2018 Feb;85:90-96. doi: 10.1016/j.jsat.2017.07.001. Epub 2017 Jul 3.
9
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019".美国阿片类药物使用障碍的治疗差距是否缩小了？2010 年至 2019 年的年度评估。
Int J Drug Policy. 2022 Dec;110:103786. doi: 10.1016/j.drugpo.2022.103786. Epub 2022 Aug 4.
10
Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder.伴有和不伴有阿片类药物使用障碍的慢性疼痛患者的感知社会支持以及阿片类药物使用障碍药物治疗的作用。
Drug Alcohol Depend. 2021 Apr 1;221:108619. doi: 10.1016/j.drugalcdep.2021.108619. Epub 2021 Feb 15.

引用本文的文献

1
A National Survey of Pediatric Emergency Medicine Clinicians' Comfort Level, Beliefs, and Experiences With Initiating Buprenorphine in the Emergency Department.一项关于儿科急诊医学临床医生在急诊科启动丁丙诺啡治疗时的舒适度、信念和经验的全国性调查。
Cureus. 2024 Sep 13;16(9):e69331. doi: 10.7759/cureus.69331. eCollection 2024 Sep.

本文引用的文献

1
Incidence of Precipitated Withdrawal During a Multisite Emergency Department-Initiated Buprenorphine Clinical Trial in the Era of Fentanyl.在芬太尼时代多中心急诊科启动的丁丙诺啡临床试验期间戒断反应诱发的发生率
JAMA Netw Open. 2023 Mar 1;6(3):e236108. doi: 10.1001/jamanetworkopen.2023.6108.
2
Buprenorphine Dispensing Among Youth Aged ≤19 Years in the United States: 2015-2020.美国≤19 岁青少年中丁丙诺啡的配给情况：2015-2020 年。
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2022-058755.
3
A Novel Inpatient Buprenorphine Induction Program for Adolescents With Opioid Use Disorder.一种针对患有阿片类物质使用障碍青少年的新型住院丁丙诺啡诱导方案。
Hosp Pediatr. 2023 Feb 1;13(2):e23-e28. doi: 10.1542/hpeds.2022-006864.
4
Buprenorphine Microdosing Cross Tapers: A Time for Change.丁丙诺啡微量滴定交叉递减法：变革之时。
Int J Environ Res Public Health. 2022 Dec 8;19(24):16436. doi: 10.3390/ijerph192416436.
5
Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection.丁丙诺啡长效皮下注射剂的开放标签、快速启动试点研究。
Am J Drug Alcohol Abuse. 2023 Jan 2;49(1):43-52. doi: 10.1080/00952990.2022.2106574. Epub 2022 Aug 24.
6
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.阿片类物质使用障碍和疼痛管理中丁丙诺啡的起始策略：系统评价。
Pharmacotherapy. 2022 May;42(5):411-427. doi: 10.1002/phar.2676. Epub 2022 Mar 25.
7
Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report.门诊环境中应用舌下丁丙诺啡/纳洛酮快速微诱导技术治疗阿片类药物使用障碍：病例报告。
J Addict Dis. 2022 Jul-Sep;40(3):439-443. doi: 10.1080/10550887.2021.1996153. Epub 2022 Jan 24.
8
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach.低剂量丁丙诺啡起始治疗：综述与实用方法
J Addict Med. 2022;16(4):399-406. doi: 10.1097/ADM.0000000000000945. Epub 2021 Dec 23.
9
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study.低剂量丁丙诺啡诱导治疗合并完全激动剂在住院阿片类药物使用障碍患者中的应用：一项回顾性队列研究。
J Addict Med. 2022;16(4):461-465. doi: 10.1097/ADM.0000000000000947. Epub 2021 Dec 23.
10
Emergency department-initiated buprenorphine protocols: A national evaluation.急诊科启动的丁丙诺啡治疗方案：一项全国性评估。
J Am Coll Emerg Physicians Open. 2021 Nov 29;2(6):e12606. doi: 10.1002/emp2.12606. eCollection 2021 Dec.

儿科患者阿片类物质使用障碍的急诊科管理

Emergency department management of opioid use disorder in pediatric patients.

作者信息

Schwarz Evan S, Dietrich Ann M, Sandelich Stephen, Hooley Gwen, Rose Emily, Ruttan Tim, Simon Erin L, Sulton Carmen, Wall Jessica

机构信息

Division of Medical Toxicology Department of Emergency Medicine University of California Los Angeles Los Angeles California USA.

Department of Emergency Medicine Prisma Health Greenville South Carolina USA.

出版信息

J Am Coll Emerg Physicians Open. 2024 Aug 25;5(5):e13265. doi: 10.1002/emp2.13265. eCollection 2024 Oct.

DOI:10.1002/emp2.13265
PMID:39193084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11345534/
Abstract

Opioid use disorder (OUD) has emerged as a significant public health crisis affecting individuals across all age groups. However, there remains a critical gap in understanding the specific nuances and challenges associated with OUD in pediatric populations. This article provides a comprehensive review of the epidemiology, definition of OUD, screening recommendations for OUD, and evidence-based management strategies for OUD in pediatric patients.

摘要

阿片类物质使用障碍（OUD）已成为一场影响所有年龄组人群的重大公共卫生危机。然而，在理解儿科人群中与阿片类物质使用障碍相关的具体细微差别和挑战方面，仍存在关键差距。本文全面综述了阿片类物质使用障碍的流行病学、定义、筛查建议以及儿科患者阿片类物质使用障碍的循证管理策略。